new immunotherapeutic methods , particularly cyclosporine , monoclonal antibodies ( against t cells , cd4 and t cell receptor molecules and ia antigens ) and autoantigen-specific vaccination open new major therapeutic perspectives that presage major improvement in the prognosis of these diseases .
C0039194
t cells
C0034790
t cell receptor